Global Viral Vectors and Plasmid DNA Manufacturing Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Viral Vectors and Plasmid DNA Manufacturing Market Overview

• 1.1 Product Overview and Scope of Viral Vectors and Plasmid DNA Manufacturing
• 1.2 Classification of Viral Vectors and Plasmid DNA Manufacturing by Types
  • 1.2.1 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Comparison by Types (2019-2024)
  • 1.2.2 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Types in 2018
  • 1.2.3 Plasmid DNA
  • 1.2.4 Viral Vectors
• 1.3 Global Viral Vectors and Plasmid DNA Manufacturing Market by Application
  • 1.3.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Size and Market Share Comparison by Applications (2014-2024)
  • 1.3.2 Cancers
  • 1.3.3 Inherited Disorders
  • 1.3.4 Viral Infections
  • 1.3.5 Others
• 1.4 Global Viral Vectors and Plasmid DNA Manufacturing Market by Regions
  • 1.4.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Size (Million USD) Comparison by Regions (2014-2024)
  • 1.4.1 North America (USA, Canada and Mexico) Viral Vectors and Plasmid DNA Manufacturing Status and Prospect (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Viral Vectors and Plasmid DNA Manufacturing Status and Prospect (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Viral Vectors and Plasmid DNA Manufacturing Status and Prospect (2014-2024)
  • 1.4.4 South America (Brazil, Argentina, Colombia) Viral Vectors and Plasmid DNA Manufacturing Status and Prospect (2014-2024)
  • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Viral Vectors and Plasmid DNA Manufacturing Status and Prospect (2014-2024)
• 1.5 Global Market Size of Viral Vectors and Plasmid DNA Manufacturing (2014-2024)

2 Manufacturers Profiles

• 2.1 BioReliance
  • 2.1.1 Business Overview
  • 2.1.2 Viral Vectors and Plasmid DNA Manufacturing Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 BioReliance Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2017-2018)
• 2.2 Cobra Biologics
  • 2.2.1 Business Overview
  • 2.2.2 Viral Vectors and Plasmid DNA Manufacturing Type and Applications
    • 2.2.2.1 Product A
    • 2.2.2.2 Product B
  • 2.2.3 Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2017-2018)
• 2.3 Oxford BioMedica
  • 2.3.1 Business Overview
  • 2.3.2 Viral Vectors and Plasmid DNA Manufacturing Type and Applications
    • 2.3.2.1 Product A
    • 2.3.2.2 Product B
  • 2.3.3 Oxford BioMedica Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2017-2018)
• 2.4 UniQure
  • 2.4.1 Business Overview
  • 2.4.2 Viral Vectors and Plasmid DNA Manufacturing Type and Applications
    • 2.4.2.1 Product A
    • 2.4.2.2 Product B
  • 2.4.3 UniQure Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2017-2018)
• 2.5 FinVector
  • 2.5.1 Business Overview
  • 2.5.2 Viral Vectors and Plasmid DNA Manufacturing Type and Applications
    • 2.5.2.1 Product A
    • 2.5.2.2 Product B
  • 2.5.3 FinVector Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2017-2018)
• 2.6 MolMed
  • 2.6.1 Business Overview
  • 2.6.2 Viral Vectors and Plasmid DNA Manufacturing Type and Applications
    • 2.6.2.1 Product A
    • 2.6.2.2 Product B
  • 2.6.3 MolMed Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2017-2018)
• 2.7 MassBiologics
  • 2.7.1 Business Overview
  • 2.7.2 Viral Vectors and Plasmid DNA Manufacturing Type and Applications
    • 2.7.2.1 Product A
    • 2.7.2.2 Product B
  • 2.7.3 MassBiologics Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2017-2018)
• 2.8 Richter-Helm
  • 2.8.1 Business Overview
  • 2.8.2 Viral Vectors and Plasmid DNA Manufacturing Type and Applications
    • 2.8.2.1 Product A
    • 2.8.2.2 Product B
  • 2.8.3 Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2017-2018)
• 2.9 FUJIFILM Diosynth Biotechnologies
  • 2.9.1 Business Overview
  • 2.9.2 Viral Vectors and Plasmid DNA Manufacturing Type and Applications
    • 2.9.2.1 Product A
    • 2.9.2.2 Product B
  • 2.9.3 FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2017-2018)
• 2.10 Lonza
  • 2.10.1 Business Overview
  • 2.10.2 Viral Vectors and Plasmid DNA Manufacturing Type and Applications
    • 2.10.2.1 Product A
    • 2.10.2.2 Product B
  • 2.10.3 Lonza Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2017-2018)
• 2.11 Aldevron
  • 2.11.1 Business Overview
  • 2.11.2 Viral Vectors and Plasmid DNA Manufacturing Type and Applications
    • 2.11.2.1 Product A
    • 2.11.2.2 Product B
  • 2.11.3 Aldevron Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2017-2018)
• 2.12 Eurogentec
  • 2.12.1 Business Overview
  • 2.12.2 Viral Vectors and Plasmid DNA Manufacturing Type and Applications
    • 2.12.2.1 Product A
    • 2.12.2.2 Product B
  • 2.12.3 Eurogentec Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2017-2018)
• 2.13 Cell and Gene Therapy Catapult
  • 2.13.1 Business Overview
  • 2.13.2 Viral Vectors and Plasmid DNA Manufacturing Type and Applications
    • 2.13.2.1 Product A
    • 2.13.2.2 Product B
  • 2.13.3 Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2017-2018)
• 2.14 Biovian
  • 2.14.1 Business Overview
  • 2.14.2 Viral Vectors and Plasmid DNA Manufacturing Type and Applications
    • 2.14.2.1 Product A
    • 2.14.2.2 Product B
  • 2.14.3 Biovian Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2017-2018)
• 2.15 Brammer Bio
  • 2.15.1 Business Overview
  • 2.15.2 Viral Vectors and Plasmid DNA Manufacturing Type and Applications
    • 2.15.2.1 Product A
    • 2.15.2.2 Product B
  • 2.15.3 Brammer Bio Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2017-2018)
• 2.16 VGXI
  • 2.16.1 Business Overview
  • 2.16.2 Viral Vectors and Plasmid DNA Manufacturing Type and Applications
    • 2.16.2.1 Product A
    • 2.16.2.2 Product B
  • 2.16.3 VGXI Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2017-2018)
• 2.17 PlasmidFactory
  • 2.17.1 Business Overview
  • 2.17.2 Viral Vectors and Plasmid DNA Manufacturing Type and Applications
    • 2.17.2.1 Product A
    • 2.17.2.2 Product B
  • 2.17.3 PlasmidFactory Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2017-2018)

3 Global Viral Vectors and Plasmid DNA Manufacturing Market Competition, by Players

• 3.1 Global Viral Vectors and Plasmid DNA Manufacturing Revenue and Share by Players (2014-2019)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Viral Vectors and Plasmid DNA Manufacturing Players Market Share
  • 3.2.2 Top 10 Viral Vectors and Plasmid DNA Manufacturing Players Market Share
• 3.3 Market Competition Trend

4 Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Regions

• 4.1 Global Viral Vectors and Plasmid DNA Manufacturing Revenue and Market Share by Regions
• 4.2 North America Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2014-2019)
• 4.3 Europe Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2014-2019)
• 4.4 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2014-2019)
• 4.5 South America Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2014-2019)
• 4.6 Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2014-2019)

5 North America Viral Vectors and Plasmid DNA Manufacturing Revenue by Countries

• 5.1 North America Viral Vectors and Plasmid DNA Manufacturing Revenue by Countries (2014-2019)
• 5.2 USA Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2014-2019)
• 5.3 Canada Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2014-2019)
• 5.4 Mexico Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2014-2019)

6 Europe Viral Vectors and Plasmid DNA Manufacturing Revenue by Countries

• 6.1 Europe Viral Vectors and Plasmid DNA Manufacturing Revenue by Countries (2014-2019)
• 6.2 Germany Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2014-2019)
• 6.3 UK Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2014-2019)
• 6.4 France Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2014-2019)
• 6.5 Russia Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2014-2019)
• 6.6 Italy Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Revenue by Countries

• 7.1 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Revenue by Countries (2014-2019)
• 7.2 China Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2014-2019)
• 7.3 Japan Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2014-2019)
• 7.4 Korea Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2014-2019)
• 7.5 India Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2014-2019)
• 7.6 Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2014-2019)

8 South America Viral Vectors and Plasmid DNA Manufacturing Revenue by Countries

• 8.1 South America Viral Vectors and Plasmid DNA Manufacturing Revenue by Countries (2014-2019)
• 8.2 Brazil Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2014-2019)
• 8.3 Argentina Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2014-2019)
• 8.4 Colombia Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Viral Vectors and Plasmid DNA Manufacturing by Countries

• 9.1 Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Revenue by Countries (2014-2019)
• 9.2 Saudi Arabia Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2014-2019)
• 9.3 UAE Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2014-2019)
• 9.4 Egypt Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2014-2019)
• 9.5 Nigeria Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2014-2019)
• 9.6 South Africa Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2014-2019)

10 Global Viral Vectors and Plasmid DNA Manufacturing Market Segment by Type

• 10.1 Global Viral Vectors and Plasmid DNA Manufacturing Revenue and Market Share by Type (2014-2019)
• 10.2 Global Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Type (2019-2024)
• 10.3 Plasmid DNA Revenue Growth Rate (2014-2024)
• 10.4 Viral Vectors Revenue Growth Rate (2014-2024)

11 Global Viral Vectors and Plasmid DNA Manufacturing Market Segment by Application

• 11.1 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Application (2014-2019)
• 11.2 Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Application (2019-2024)
• 11.3 Cancers Revenue Growth (2014-2019)
• 11.4 Inherited Disorders Revenue Growth (2014-2019)
• 11.5 Viral Infections Revenue Growth (2014-2019)
• 11.6 Others Revenue Growth (2014-2019)

12 Global Viral Vectors and Plasmid DNA Manufacturing Market Size Forecast (2019-2024)

• 12.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Size Forecast (2019-2024)
• 12.2 Global Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Regions (2019-2024)
• 12.3 North America Viral Vectors and Plasmid DNA Manufacturing Revenue Market Forecast (2019-2024)
• 12.4 Europe Viral Vectors and Plasmid DNA Manufacturing Revenue Market Forecast (2019-2024)
• 12.5 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Revenue Market Forecast (2019-2024)
• 12.6 South America Viral Vectors and Plasmid DNA Manufacturing Revenue Market Forecast (2019-2024)
• 12.7 Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology